Interleukin-6 in Rheumatoid Arthritis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 07 2020
Historique:
received: 02 07 2020
revised: 18 07 2020
accepted: 20 07 2020
entrez: 29 7 2020
pubmed: 29 7 2020
medline: 13 8 2020
Statut: epublish

Résumé

The role of interleukin (IL)-6 in health and disease has been under a lot of scrutiny in recent years, particularly during the recent COVID-19 pandemic. The inflammatory pathways in which IL-6 is involved are also partly responsible of the development and progression of rheumatoid arthritis (RA), opening interesting perspectives in terms of therapy. Anti-IL-6 drugs are being used with variable degrees of success in other diseases and are being tested in RA. Results have been encouraging, particularly when anti-IL-6 has been used with other drugs, such as metothrexate (MTX). In this review we discuss the main immunologic aspects that make anti-IL-6 a good candidate in RA, but despite the main therapeutic options available to target IL-6, no gold standard treatment has been established so far.

Identifiants

pubmed: 32718086
pii: ijms21155238
doi: 10.3390/ijms21155238
pmc: PMC7432115
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
IL6 protein, human 0
Interleukin-6 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Rheumatol. 2014 Jan;41(1):15-23
pubmed: 24187110
Arthritis Rheum. 1989 Nov;32(11):1345-55
pubmed: 2479385
Ann Rheum Dis. 2012 Jul;71(7):1243-8
pubmed: 22532637
Semin Immunopathol. 2017 Jun;39(4):365-383
pubmed: 28213794
Cytokine Growth Factor Rev. 2018 Dec;44:38-50
pubmed: 30340925
Immunotherapy. 2018 Jan;10(1):57-65
pubmed: 29043871
Clin Exp Rheumatol. 2020 Sep-Oct;38(5):864-873
pubmed: 31820723
Expert Rev Clin Immunol. 2017 Jun;13(6):535-551
pubmed: 28494214
Immunity. 1997 Mar;6(3):315-25
pubmed: 9075932
Arthritis Res Ther. 2005;7(4):R784-95
pubmed: 15987480
J Dent Res. 2010 Dec;89(12):1389-94
pubmed: 20940360
Biochem J. 1990 Feb 1;265(3):621-36
pubmed: 1689567
Arthritis Rheum. 1987 Nov;30(11):1205-13
pubmed: 2446635
Cytokine Growth Factor Rev. 2015 Oct;26(5):475-87
pubmed: 26189695
Lancet. 2008 Mar 22;371(9617):987-97
pubmed: 18358926
Rev Recent Clin Trials. 2018;13(3):210-214
pubmed: 29542422
Drugs. 2018 Jun;78(9):929-940
pubmed: 29931592
Drug Des Devel Ther. 2017 May 24;11:1593-1603
pubmed: 28579757
Ann Rheum Dis. 2011 May;70(5):755-9
pubmed: 21187298
Ann Rheum Dis. 2020 Jun;79(6):744-759
pubmed: 32033937
Mod Rheumatol. 2016;26(1):15-23
pubmed: 26358841
Pharmacol Ther. 2014 Feb;141(2):125-39
pubmed: 24076269
J Biol Regul Homeost Agents. 2019 Apr 03;33(2):315-319
pubmed: 30942065
Clin Rheumatol. 2019 Nov;38(11):2977-2994
pubmed: 31367943
RMD Open. 2018 Nov 16;4(2):e000731
pubmed: 30564449
J Oral Microbiol. 2012;4:
pubmed: 22347541
Mol Immunol. 2018 Jul;99:171-181
pubmed: 29793131
Front Immunol. 2017 Aug 16;8:926
pubmed: 28861079
BioDrugs. 2018 Dec;32(6):531-546
pubmed: 30488231
Cold Spring Harb Perspect Biol. 2014 Sep 04;6(10):a016295
pubmed: 25190079
N Engl J Med. 2011 Dec 8;365(23):2205-19
pubmed: 22150039
Bioorg Med Chem. 2020 Mar 1;28(5):115327
pubmed: 31992476
J Affect Disord. 2013 Sep 25;150(3):736-44
pubmed: 23870425
J Exp Med. 2020 May 4;217(5):
pubmed: 32267936
Clin Cancer Res. 2015 Mar 15;21(6):1248-57
pubmed: 25589616
BMC Musculoskelet Disord. 2015 Mar 12;16:51
pubmed: 25879761
Int J Mol Sci. 2018 Nov 09;19(11):
pubmed: 30423923
Rheumatology (Oxford). 2014 Jul;53(7):1321-31
pubmed: 24609058
Expert Rev Clin Immunol. 2017 Sep;13(9):849-866
pubmed: 28540751
Rheumatol Ther. 2018 Jun;5(1):21-42
pubmed: 29502236
Front Med. 2019 Oct;13(5):610-617
pubmed: 31571160
Biochem Pharmacol. 2019 Jul;165:152-169
pubmed: 30910693
Immunotherapy. 2016 Jul;8(8):959-70
pubmed: 27381687
Sao Paulo Med J. 2019 Nov-Dec;137(6):517-522
pubmed: 32159638
Lancet. 2016 Oct 22;388(10055):2023-2038
pubmed: 27156434
Hum Immunol. 1990 Jun;28(2):252-7
pubmed: 2351572
Arthritis Rheumatol. 2015 Oct;67(10):2591-600
pubmed: 26138593
Cells. 2018 Nov 22;7(12):
pubmed: 30469466
Infect Dis Clin North Am. 2020 Jun;34(2):211-234
pubmed: 32334983
Ann Rheum Dis. 2018 Jun;77(6):905-910
pubmed: 29592917
BioDrugs. 2003;17(5):369-72
pubmed: 14498766
Ann Rheum Dis. 2010 Jan;69(1):88-96
pubmed: 19297346
Arthritis Rheum. 2012 Aug;64(8):2499-503
pubmed: 22488116
J Biol Regul Homeost Agents. 2020 Mar 14;34(2):327-331
pubmed: 32171193
FEMS Microbiol Rev. 2019 Jan 1;43(1):1-18
pubmed: 30219863
Adv Ther. 2018 Oct;35(10):1535-1563
pubmed: 30128641
Clin Rheumatol. 2018 Mar;37(3):631-637
pubmed: 29101672
Arthritis Rheum. 2008 Oct;58(10):2968-80
pubmed: 18821691
EBioMedicine. 2015 Nov 17;2(12):2037-45
pubmed: 26844284
Arch Pharm Res. 2015;38(5):575-84
pubmed: 25648633
J Immunol. 2001 Nov 1;167(9):5395-403
pubmed: 11673558
Nat Immunol. 2015 May;16(5):448-57
pubmed: 25898198
Br J Clin Pharmacol. 2011 Aug;72(2):270-81
pubmed: 21392075
Am J Pathol. 2010 Jul;177(1):166-75
pubmed: 20508031
BMC Nephrol. 2018 Oct 11;19(1):263
pubmed: 30314457
Expert Rev Clin Immunol. 2018 Jul;14(7):539-547
pubmed: 29925278
Lancet Haematol. 2020 Mar;7(3):e209-e217
pubmed: 32027862
Drug Des Devel Ther. 2018 Dec 19;13:57-70
pubmed: 30587928
Ann Rheum Dis. 2007 Sep;66(9):1162-7
pubmed: 17485422
Int J Rheum Dis. 2017 Jul;20(7):859-869
pubmed: 28160426
RMD Open. 2015 Aug 05;1(1):e000127
pubmed: 26535144
World J Orthop. 2014 Sep 18;5(4):516-36
pubmed: 25232528
Semin Arthritis Rheum. 2014 Oct;44(2):123-30
pubmed: 24973898
J Autoimmun. 2020 Jul;111:102452
pubmed: 32291137
Nat Med. 2015 Aug;21(8):895-905
pubmed: 26214836
Clin Exp Rheumatol. 2015 Jul-Aug;33(4):551-8
pubmed: 26203933
Proc Natl Acad Sci U S A. 1989 Aug;86(15):5953-7
pubmed: 2788282
J Interferon Cytokine Res. 2005 Jul;25(7):407-13
pubmed: 16022585
Arthritis Rheum. 2011 Mar;63(3):609-21
pubmed: 21360490
Ther Adv Musculoskelet Dis. 2010 Oct;2(5):247-56
pubmed: 22870451
Lancet Oncol. 2014 Aug;15(9):966-74
pubmed: 25042199
Front Biosci (Landmark Ed). 2012 Jun 01;17:2306-26
pubmed: 22652781
Med Gas Res. 2020 Jul-Sep;10(3):134-138
pubmed: 33004712
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Clin Exp Rheumatol. 2018 Mar-Apr;36(2):175-184
pubmed: 29716677
Drug Des Devel Ther. 2014 Mar 28;8:349-64
pubmed: 24729685
Semin Immunopathol. 2019 May;41(3):283-297
pubmed: 30891627
RMD Open. 2019 Oct 18;5(2):e001017
pubmed: 31673415
Arthritis Rheumatol. 2017 Feb;69(2):277-290
pubmed: 27860410
Cell Rep Med. 2020 May 19;1(2):100019
pubmed: 32501455
Clin Ther. 2016 May;38(5):1017-28
pubmed: 27021609

Auteurs

Franco Pandolfi (F)

Allergy and Clinical Immunology, Fondazione Policlinico Universitario A, Gemelli IRCCS, Catholic University, 00168 Rome, Italy.

Laura Franza (L)

Emergency Medicine, Fondazione Policlinico Universitario A, Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Valentina Carusi (V)

Allergy and Clinical Immunology, Fondazione Policlinico Universitario A, Gemelli IRCCS, Catholic University, 00168 Rome, Italy.

Simona Altamura (S)

Allergy and Clinical Immunology, Fondazione Policlinico Universitario A, Gemelli IRCCS, Catholic University, 00168 Rome, Italy.

Gloria Andriollo (G)

Allergy and Clinical Immunology, Fondazione Policlinico Universitario A, Gemelli IRCCS, Catholic University, 00168 Rome, Italy.

Eleonora Nucera (E)

Allergy and Clinical Immunology, Fondazione Policlinico Universitario A, Gemelli IRCCS, Catholic University, 00168 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH